Skip to main content
PACB logo

PACB · Pacific Biosciences Of California, Inc. · Analyst Estimates

Track PACB — free
$2.51 +0.00 (+0.07%)
Market Cap
$503.55M
Shares
310.83M
Volume · Oct 2 25.93M Avg daily vol (3M) 8.5M

Analyst Estimates

Compare analyst forecasts for Pacific Biosciences Of California, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 21:34 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.53
-0.51358
-0.487
—
-0.5095
-0.5064
-0.5145
-0.5058
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
4
1
1
0
Revenue
USD
Publication date not stated
153300000
158898860
162297070
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.52
-0.40185
-0.231
—
-0.3985
-0.3966
-0.40517
-0.3968
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
3
1
2
0
Revenue
USD
Publication date not stated
171700000
184333770
198700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.14
-0.12865
-0.109
—
-0.1265
-0.1272
-0.12983
-0.1264
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
3
1
1
0
Revenue
USD
Publication date not stated
37400000
39621340
41816440
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.14
-0.13017
-0.116
—
-0.12933
-0.1306
-0.131
-0.1308
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
3
1
2
0
Revenue
USD
Publication date not stated
39800000
43065870
44900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1299130 CUSIP 69404D108 13F (30d) 5 filings 5 filers Visit website Investor relations